To print: Select File and then Print from your browser's menu --------------------------------------------------------------------------------------- Title: Exorex New Breakthrough Psoriasis Medication Launched URL: http://www.pslgroup.com/dg/DAFA.htm Doctor's Guide November 12, 1996
BOCA RATON, Fla.—Nov. 12, 1996 -- IMX Corp. (NASDAQ:IMXN), the exclusive United States distributor of Exorex(tm), a new breakthrough treatment for psoriasis, has announced the retail launch of Exorex in all K & B Drugs. Beginning Nov. 11, the Exorex Treatment Program will be available for the first time over-the-counter chain-wide in all K & B drug stores in New Orleans, Baton Rouge and Shreveport, La; Memphis, Tenn.; Jackson, Miss. and Mobile, Ala. Exorex, originally derived from the fatty acid of the common banana, was developed in South Africa by a psoriasis sufferer and is currently being clinically tested by leading doctors at the Psoriasis Research and Treatment Center at Boston Medical Center. Preliminary study results show significant improvement in over 80 percent of patients after three months of treatment. The retail launch will be supported by a pharmacy program, new retail packaging and an advertising campaign developed by Lewis Gace Bozell International. The pharmacy program includes pharmacy displays with take-one brochures, pharmacy posters and an informational packet for the pharmacist. A television advertising campaign is planned to support the retail launch of Exorex. "The support of K & B Drugs for our initial retail launch of Exorex is very exciting and a key component in marketing this treatment to psoriasis sufferers nationwide," said Bill Forster, president of IMX Corp. "This market retail launch is the precursor to a nationwide roll-out of Exorex in major drug store chains throughout the country." --------------------------------------------------------------------------------------------- Copyright © 1999 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content. --------------------------------------------------------------------------------------------- This news story was printed from *Doctor's Guide to the Internet* located at http://www.docguide.com --------------------------------------------------------------------------------------- Return to News Story Page This site is maintained by webmaster@pslgroup.com Please contact us with any comments, problems or bugs. All contents Copyright (c) 1998 P\S\L Consulting Group Inc. All rights reserved.